Tag: Portable Oxygen Concentrator (POC)

LONDON and PLANO, Texas – Belluscura has entered into an exclusive licensing, marketing and distribution agreement with China-based InnoMax Medical Technology to manufacture and distribute Belluscura's X-PLOR portable oxygen concentrator in China, Hong Kong, Macau and Singapore (the Territories). The agreement will also include the DISCOV-R, the Belluscura's next generation, ambulatory dual flow portable oxygen concentrator, when registration is received in the Territories for both...

LONDON and PLANO, Texas – Belluscura has received purchase orders for more than 6,500 of its DISCOV-R portable oxygen concentrators, representing about $15 million of potential revenue. The company plans to begin initial production of the POC by the end of this quarter. "We are very excited about the overwhelming interest in the DISCOV-R by online retail sellers and other medical equipment providers,” said Bob Fary, senior vice president of global sales. “Following the pre-market...

GOLETA, Calif. – Inogen has launched the Rove 6 portable oxygen concentrator in the United States with an eight-year expected service life. The company launched the Rove 6 in Europe in December. Inogen has also extended the eight-year expected service life to its Inogen One G5 POC in the United States. “In capital-based business models it is critical to maximize the value of the devices you invest in to enhance your returns,” said Nabil Shabshab, president and CEO. “We are...

SEATTLE – VARON has launched an addition to its VP series of portable oxygen concentrators, the VP-2. "We are more excited than anyone to introduce the new product to the market," said Darren Wang, CEO of VARON. "Our goal is to make oxygen therapy more accessible by providing reliable, efficient, and affordable solutions for anyone in need. With VP-2 coming out, we believe we are much closer to the goal." The VP-2 features a dual oxygen supply mode, so, in addition to traditional pulse...

LONDON and PLANO, Texas – Belluscura reported group revenue of $1.54 million for the year ended Dec. 31, 2022, compared to $420,000 the previous year. It reported adjusted losses from operations of $6.2 million vs. $4.2 million, and net cash of $2.04 million. Among its highlights for the year: built significant U.S. distribution and commenced international roll-out; established manufacturing facilities in both the U.S. and China; launched the next generation X-PLOR, with initial new standing...

LONDON, and PLANO, Texas – Belluscura has raised gross proceeds of £3 million (approximately £2.7 million net of expenses) through the issue of 12 million new ordinary shares at the issue price of 25 pence per share. The company has also announced a retail offer to raise up to £0.5 million (before expenses) through the issue of new ordinary shares of 1 penny each in the share capital of the company. Under the retail offer, up to two million new ordinary shares will be made...

ELYRIA, Ohio – Invacare announced May 8 that the company, as well as its two U.S. subsidiaries, Freedom Designs and Adaptive Switch Laboratories, successfully emerged from Chapter 11 bankruptcy on May 5.  The news comes about three months after Invacare filed for Chapter 11.  “This marks the start of a new era for Invacare,” said Geoffrey P. Purtill, president and CEO, who will continue to lead the company. “With Chapter 11 behind us, we look to renew...

CHICAGO – The medical advisory board of the Pulmonary Fibrosis Foundation (PFF) has issued a position statement on non-prescription supplemental oxygen that advises the patient community to use only devices approved by the U.S. Food and Drug Administration as prescribed by their doctor. The PFF warns that patients should not purchase an oxygen supply device without a prescription from a health care provider because doing so may lead to serious health problems. It also warns non-FDA approved...

LONDON and PLANO, Texas – Belluscura has started manufacturing its X-PLOR portable oxygen concentrator in China. This follows a manufacturing agreement announced in March 2022 with InnoMax Medical Technology to manufacture the X-PLOR in China, enabling the company to accelerate its international expansion by opening up markets in Asia and beyond. "We continue to make good progress, with manufacturing in China commencing, increased orders for X-PLOR and the tremendous reception of DISCOV-R...

LONDON and PLANO, Texas – Belluscura has announced its X-PLOR portable oxygen concentrator is now marketed in the U.S. through GoodRx. The X-PLOR will be the first medical device in its field marketed through GoodRx’s website, www.goodrx.com. "In our continued goal of broadening product distribution and making supplemental oxygen more accessible to people throughout the U.S., we are excited to have the X-PLOR marketed through GoodRx, a recognized leader in making health care more accessible...